Placebo Controlled Trial
Placebo Controlled Trial - Related Videos
06:58
Placebos in Research
0 Views •
2023
Source: Laboratories of Gary Lewandowski, Dave Strohmetz, and Natalie Ciarocco—Monmouth University Clinical research focuses on the efficacy of treatments for addressing disorders and illnesses. A challenge with this type of research is that participants often have pre-existing beliefs about the treatment, particularly expectations that the treatment will work. Though it has been practiced around the world for centuries, yoga is a relatively recent fitness craze in the United States with a...
01:54
The Placebo Effect
0 Views •
2020
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen. The placebo effect is commonly described in terms of testing the effectiveness of a new medication. Imagine that you work in a pharmaceutical company, and you think you have a new drug that is effective in treating depression. To demonstrate that your medication is effective, you run an...
08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
0 Views •
Cited by 9 •
2014
An experimental rotation chair paradigm is used to investigate whether a placebo intervention on motion sickness affects subjective outcome measures only or also affects behavioral and objective measures in a balanced placebo design.
03:26
Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
0 Views •
Cited by 5 •
2024
The protocol outlines the surgical procedure for the treatment of postamputation pain using Targeted Muscle Reinnervation (TMR). TMR will be compared with two other surgical techniques, specifically Regenerative Peripheral Nerve Interface (RPNI) and neuroma excision, followed by immediate burying within muscle under the context of an international, randomized controlled trial.
01:28
The Trial Balance
0 Views •
2025
A trial balance is a fundamental financial statement that provides a snapshot of a company's accounts and their balances at a specific point in time. It serves as an essential tool for verifying the accuracy of financial records by ensuring that the total debits equal the total credits. Typically prepared at the end of an accounting period, a trial balance lists all ledger accounts in the order they appear, with debit balances in the left column and credit balances in the right column. The two...
FAQs
Random assignment places participants into treatment or placebo groups by a chance-based process rather than by clinical characteristics or expectations. This helps distribute other influences between groups, making differences in outcomes more interpretable as effects of the treatment. In medicine, that comparison strengthens conclusions about whether a therapy produces benefits beyond changes that might occur without it.
Blinding limits knowledge of group assignments among participants, clinicians, or outcome assessors. Without that knowledge, expectations are less likely to influence reported symptoms, clinical behavior, or judgments about outcomes. The design can therefore reduce several sources of bias at once, although the specific people kept unaware may differ between trials depending on how outcomes are assessed.
The comparison helps separate effects attributable to the treatment from responses associated with expectations, natural changes in disease, or other influences affecting both groups. If the treatment group shows a different outcome from the placebo group, investigators can evaluate whether the difference is consistent with a genuine treatment effect rather than a placebo response alone.
Investigators can compare therapeutic outcomes and safety findings between the treatment and placebo groups. This provides evidence about whether the therapy offers benefits beyond the comparison intervention while also showing unwanted effects that occur during the study. Considering both dimensions supports a more complete assessment of the therapy and can contribute to regulatory decisions.
A typical workflow assigns participants at random to a treatment or placebo group, uses an intervention designed to resemble the treatment, and may blind participants, clinicians, or assessors to assignments. Investigators then compare outcomes and safety findings between groups. This structured process helps account for expectations, natural disease changes, and other potential sources of bias.
This design is useful when researchers need rigorous evidence that a therapy’s observed effects come from the treatment itself. It supports evaluation of efficacy and safety, helps distinguish pharmacological effects from placebo responses, and can provide evidence relevant to regulatory decisions. Its value is greatest when expectations and changing disease states could otherwise complicate interpretation.